[Form 4/A] BIO KEY INTERNATIONAL INC Amended Insider Trading Activity

Rhea-AI Filing Summary

Michael DePasquale, Chief Executive Officer and Director of Bio-Key International, Inc. (BKYI), amended a Form 4 to report two small open-market purchases. The filing shows purchases of 2,500 shares on 09/15/2025 at $0.75 and 1,617 shares on 09/16/2025 at $0.84, increasing his direct beneficial ownership to 102,775 shares. The amendment clarifies that this total excludes previously reported options to purchase 232 shares and warrants for 9,167 shares that were included in an earlier Form 4 filed the same day. The form is signed by Mr. DePasquale on 09/17/2025 and indicates the filing is by one reporting person.

Positive

• Reporting clarity: The amendment clarifies holdings and excludes previously reported options and warrants, improving transparency
• Insider increased direct holdings: CEO acquired a total of 4,117 shares across two days, raising direct ownership to 102,775 shares

Negative

• None.

Insights

Financial Analyst

TL;DR: CEO made modest open-market purchases, slightly increasing his direct stake to 102,775 shares; transactions are small in size.

The reported purchases on 09/15/2025 and 09/16/2025 total 4,117 shares acquired at $0.75 and $0.84 respectively, reflecting routine insider buying activity. These transactions raise the reporting person’s direct holding to 102,775 shares. The amendment clarifies that certain previously reported options and warrants (232 and 9,167 shares) are excluded from the holding total presented here. From an investor-information perspective, this filing provides transparency on insider share accumulation but the absolute share amounts are limited and appear non-transactional in scale relative to larger equity positions.

Corporate Governance Expert

TL;DR: Amendment provides corrective disclosure; filing compliance maintained with clear signing and dates.

The Form 4/A shows timely corrective reporting: an amendment executed 09/17/2025 updating transactions from 09/15/2025 and 09/16/2025 and clarifying holdings excluded from the aggregate total. The report is signed by the reporting person and filed as a single reporter submission. This strengthens record accuracy and meets Section 16 transparency expectations. No departures, option cancellations, or other governance events are disclosed.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

DEPASQUALE MICHAEL W

(Last) (First) (Middle)

C/O BIO-KEY INTERNATIONAL, INC.

101 CRAWFORDS CORNER RD, SUITE 4116

(Street)

HOLMDEL NJ 07733

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
BIO KEY INTERNATIONAL INC [ BKYI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)	X	Other (specify below)
	Chief Executive Officer		Chairman

3. Date of Earliest Transaction (Month/Day/Year)
09/15/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)
09/17/2025

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/15/2025		P	V	2,500	A	$0.75	101,158(1)	D
Common Stock	09/16/2025		P	V	1,617	A	$0.84	102,775(1)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Holdings do not include options to purchase 232 shares and 9,167 shares issuable upon exercise of warrants, which were originally included in the form 4 filed earlier today.

	/s/ Michael DePasquale	09/17/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transactions did BKYI CEO Michael DePasquale report on the amended Form 4/A?

He reported open-market purchases of 2,500 shares on 09/15/2025 at $0.75 and 1,617 shares on 09/16/2025 at $0.84.

What is Michael DePasquale's total direct beneficial ownership after the reported transactions?

The filing reports 102,775 shares beneficially owned following the transactions.

Does the Form 4/A include options or warrants in the reported holding total?

No. The amendment states holdings do not include options to purchase 232 shares and 9,167 shares issuable upon exercise of warrants that were included in an earlier Form 4.

When was the amendment signed and filed?

The Form 4/A is signed by Michael DePasquale on 09/17/2025 and reports transactions dated 09/15/2025 and 09/16/2025.

Was this filing submitted by more than one reporting person?

No. The form indicates it was filed by one reporting person.